Oct 2026 $7 M Private placement after listing $2 to $10 million 9
OS Therapies Inc: Private sale, Oct 2026 × Investors in this round 9 investors had bought by the notice of Oct 23, 2026: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $12 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $859,774
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Francis Knuettel II · Executive Officer · Chief Financial Officer Kerry Clem · Executive Officer · Chief Commercial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril McKean Dieser · Director Craig Eagle · Director John Ciccio · Director Olivier Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Francis Knuettel II, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 23, 2026. Read the notice at the SEC .
equity, options SEC Aug 2026 $5 M Private placement after listing $2 to $10 million 10
OS Therapies Inc: Private sale, Aug 2026 × Investors in this round 10 investors had bought by the notice of Aug 25, 2026: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $500,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director Craig P. Eagle · Director John P. Ciccio · Director Olivier P. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Christopher P. Acevedo, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 25, 2026. Read the notice at the SEC .
equity, debt, options SEC Jun 2026 $2 M Private placement after listing Under $2 million 1
OS Therapies Inc: Private sale, Jun 2026 × Investors in this round 1 investor had bought by the notice of Jul 16, 2026: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $9 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director Craig P. Eagle · Director John P. Ciccio · Director Olivier P. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher P. Acevedo, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 16, 2026. Read the notice at the SEC .
debt, options SEC Mar 2026 $2 M Private placement after listing $2 to $10 million 9
OS Therapies Inc: Private sale, Mar 2026 × Investors in this round 9 investors had bought by the notice of Mar 6, 2026: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $140,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director John P. Ciccio · Director Karim P. Galzahr · Director Olivier P. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Christopher P. Acevedo, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 6, 2026. Read the notice at the SEC .
debt, options SEC Jan 2026 $4 M Private placement after listing $2 to $10 million 9
OS Therapies Inc: Private sale, Jan 2026 × Investors in this round 9 investors had bought by the notice of Jan 20, 2026: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $8 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $627,550
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director John P. Ciccio · Director Karim P. Galzahr · Director Olivier P. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Christopher P. Acevedo, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 20, 2026. Read the notice at the SEC .
equity, options SEC Sep 2025 $4 M Private placement after listing $2 to $10 million 10
OS Therapies Inc: Private sale, Sep 2025 × Investors in this round 10 investors had bought by the notice of Sep 10, 2025: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $56,667
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director John P. Ciccio · Director Karim P. Galzahr · Director Olivier P. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Christopher P. Acevedo, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 10, 2025. Read the notice at the SEC .
equity, options SEC Jun 2025 $4 M Private placement after listing $2 to $10 million 27
OS Therapies Inc: Private sale, Jun 2025 × Investors in this round 27 investors had bought by the notice of Jul 16, 2025: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $210,839
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Paul A. Romness · Executive Officer, Director · Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director John P. Ciccio · Director Karim P. Galzahr · Director Olivier P. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Christopher P. Acevedo, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 16, 2025. Read the notice at the SEC .
equity, options SEC Dec 2024 $7 M No. 2 $2 to $10 million 34
OS Therapies Inc: Raise no. 2, Dec 2024 × Investors in this round 34 investors had bought by the notice of Jan 22, 2025: 34 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $10 M offered; $3 M still to sell
Smallest investment taken $10,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $240,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Christopher P. Acevedo · Executive Officer · Chief Financial Officer Gerald P. Commissiong · Executive Officer · Chief Business Officer Paul A. Romness · Executive Officer, Director · Founder, Chairman, President and Chief Executive Officer Robert G. Petit · Executive Officer · Chief Medical Officer and Chief Scientific Officer Avril P. McKean Dieser · Director John P. Ciccio · Director Olivier R. Jarry · Director Theodore F. Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Brookline Capital Markets (CRD 44656) · broker-dealer Arcadia Securities, LLC (CRD 44656) · New York, New York Sold in AL, CA, FL, GA, ID, IL, LA, MD, MN, NJ, NV, NY, TX, VA, WA, WI, WY Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in AL, CA, FL, GA, ID, IL, LA, MD, MN, NJ, NV, NY, TX, VA, WA, WI, WY Remarks in the notice On the amounts: “After selling $7,103,000 in the Offering, the Issuer has determined to close the Offering.”Signed by Paul A. Romness, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 22, 2025. Read the notice at the SEC .
equity, options SEC Nov 2022 $2 M No. 1 $2 to $10 million 11
OS Therapies Inc: Raise no. 1, Nov 2022 × Investors in this round 11 investors had bought by the notice of Jan 11, 2023: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $50,000
What was sold equity, options or other rights to buy securities, other: Convertible promissory notes including underlying Class A common stock issuable upon conversion of such notes. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Acevedo · Executive Officer · Chief Financial Officer Jutta Wanner · Executive Officer · Chief Technology Officer Paul Romness · Executive Officer, Director · President and Chief Executive Officer Robert Petit · Executive Officer · Chief Scientific Officer and Chief Medical Officer Colin Goddard · Director Joacim Borg · Director John Ciccio · Director Theodore Search · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Noble Capital Markets, Inc. (CRD 15768) · New York, New York Sold in all US states Signed by Paul Romness, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 11, 2023. Read the notice at the SEC .
equity, options SEC